NO179513C - 2-substituerte kinolylmetoksy-fenyleddiksyrederivater, legemidler inneholdende dem samt deres anvendelse for fremstilling av legemidler - Google Patents

2-substituerte kinolylmetoksy-fenyleddiksyrederivater, legemidler inneholdende dem samt deres anvendelse for fremstilling av legemidler

Info

Publication number
NO179513C
NO179513C NO932709A NO932709A NO179513C NO 179513 C NO179513 C NO 179513C NO 932709 A NO932709 A NO 932709A NO 932709 A NO932709 A NO 932709A NO 179513 C NO179513 C NO 179513C
Authority
NO
Norway
Prior art keywords
carbon atoms
chain
straight
hydroxyl
phenyl
Prior art date
Application number
NO932709A
Other languages
English (en)
Other versions
NO179513B (no
NO932709L (no
NO932709D0 (no
Inventor
Michael Matzke
Klaus-Helmut Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Reiner Muller-Peddinghaus
Armin Hatzelmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO932709D0 publication Critical patent/NO932709D0/no
Publication of NO932709L publication Critical patent/NO932709L/no
Publication of NO179513B publication Critical patent/NO179513B/no
Publication of NO179513C publication Critical patent/NO179513C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
NO932709A 1992-08-11 1993-07-27 2-substituerte kinolylmetoksy-fenyleddiksyrederivater, legemidler inneholdende dem samt deres anvendelse for fremstilling av legemidler NO179513C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226519A DE4226519A1 (de) 1992-08-11 1992-08-11 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate

Publications (4)

Publication Number Publication Date
NO932709D0 NO932709D0 (no) 1993-07-27
NO932709L NO932709L (no) 1994-02-14
NO179513B NO179513B (no) 1996-07-15
NO179513C true NO179513C (no) 1996-10-23

Family

ID=6465285

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932709A NO179513C (no) 1992-08-11 1993-07-27 2-substituerte kinolylmetoksy-fenyleddiksyrederivater, legemidler inneholdende dem samt deres anvendelse for fremstilling av legemidler

Country Status (22)

Country Link
US (1) US5597833A (no)
EP (1) EP0582908B1 (no)
JP (1) JPH06157463A (no)
KR (1) KR940003936A (no)
CN (1) CN1087337A (no)
AT (1) ATE166645T1 (no)
AU (1) AU668574B2 (no)
CA (1) CA2103521A1 (no)
CZ (1) CZ151193A3 (no)
DE (2) DE4226519A1 (no)
DK (1) DK0582908T3 (no)
ES (1) ES2117070T3 (no)
FI (1) FI933512A (no)
HU (1) HUT70041A (no)
IL (1) IL106622A (no)
MX (1) MX9304582A (no)
MY (1) MY108877A (no)
NO (1) NO179513C (no)
NZ (1) NZ248343A (no)
PL (1) PL300026A1 (no)
SK (1) SK86593A3 (no)
ZA (1) ZA935795B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US6069151A (en) * 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
GB2356139A (en) * 1999-11-15 2001-05-16 Bayer Ag Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases
KR20070001922A (ko) 2003-12-12 2007-01-04 와이어쓰 심장혈관질환 치료에 유용한 퀴놀린
BRPI0615150A2 (pt) * 2005-08-10 2017-06-20 Takeda Pharmaceuticals Co agente para a profilaxia ou tratamento de diabete, sensibilizador de insulina, composto, pró-droga, agente farmacêutico, e, uso do composto ou um sal do mesmo ou uma pró-droga do mesmo
EP2086531A4 (en) 2006-11-30 2009-09-30 Amira Pharmaceuticals Inc COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
ES2878405T3 (es) 2014-02-04 2021-11-18 Bioscience Pharma Partners Llc Uso de inhibidores de flap para reducir la lesión mediada por neuroinflamación en el sistema nervioso central

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH0742488Y2 (ja) * 1989-05-23 1995-10-04 川崎重工業株式会社 移動床型脱じん・反応装置
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
KR940003936A (ko) 1994-03-14
DE59308603D1 (de) 1998-07-02
NO179513B (no) 1996-07-15
HU9302313D0 (en) 1993-10-28
FI933512A0 (fi) 1993-08-09
ATE166645T1 (de) 1998-06-15
CZ151193A3 (en) 1994-03-16
NO932709L (no) 1994-02-14
DE4226519A1 (de) 1994-02-17
EP0582908B1 (de) 1998-05-27
ZA935795B (en) 1994-03-07
NZ248343A (en) 1995-03-28
MY108877A (en) 1996-11-30
AU668574B2 (en) 1996-05-09
ES2117070T3 (es) 1998-08-01
JPH06157463A (ja) 1994-06-03
PL300026A1 (en) 1994-03-21
DK0582908T3 (da) 1999-01-18
HUT70041A (en) 1995-09-28
NO932709D0 (no) 1993-07-27
IL106622A0 (en) 1993-12-08
CA2103521A1 (en) 1994-02-12
AU4425393A (en) 1994-02-17
MX9304582A (es) 1994-02-28
CN1087337A (zh) 1994-06-01
IL106622A (en) 1997-02-18
FI933512A (fi) 1994-02-12
US5597833A (en) 1997-01-28
SK86593A3 (en) 1994-06-08
EP0582908A1 (de) 1994-02-16

Similar Documents

Publication Publication Date Title
MX9203744A (es) Analogos de camptotecina solubles en agua utiles para inhibir el crecimiento de celulas de tumor de animal.
BR0014137A (pt) Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica
NO179513C (no) 2-substituerte kinolylmetoksy-fenyleddiksyrederivater, legemidler inneholdende dem samt deres anvendelse for fremstilling av legemidler
NO307463B1 (no) Galantaminderivater, en fremgangsmõte for fremstilling samt deres anvendelse som medikamenter
EP0614661A3 (en) Benzylidene and cinnamylidene malononitrile derivatives to inhibit proliferative processes in mammalian cells.
HU904956D0 (en) Process for producing benzopyrane derivatives and pharmaceutical preparatives containing such active agents
HUP9801725A1 (hu) Új benzimidazol-, benzoxazol- és benzotiazolszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HUT70414A (en) Geneserine derivatives as cholinesterase inhibitors and pharmaceutical compositions containing them
MX2023002619A (es) Derivados nitrados de psilocibina y uso de los mismos para modular el receptor 5-ht2a y para tratar un trastorno psiquiatrico.
ATE67193T1 (de) 6-phenyl-pyridazin-verbindungen.
SE8802412D0 (sv) Thiourea derivatives
EP1722781A2 (en) Maleiimide anti-tumor phosphatase inhibitors
AU560420B2 (en) Phenoxymethyl pyridine derivatives
EP0290285A3 (en) Bicyclic sulfonamide derivatives and their preparation, their use and formulations containing them
ATE43140T1 (de) Derivate von enzym-hemmender griseolsaeure und deren verwendung.
DE69409734D1 (de) Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
ES497467A0 (es) Un procedimiento para la preparacion de derivados de imadazol n- sustituidos, o su sales de adicion de acido.
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
TH10123B (th) อนุพันธ์ของอินโดล
FR2450106A1 (fr) Compositions pharmaceutiques ou veterinaires renfermant une quantite physiologiquement active d'une phenylethylamine, a activite de stimulation sexuelle